Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024)
Galectin Therapeutics' (GALT) quarterly Accumulated Depreciation came in at $74000.0 in Q4 2024, little changed year-on-year from $74000.0 in Q1 2024, and little changed quarter-over-quarter from $74000.0 in Q4 2023.
Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024) Analysis & Trends
Galectin Therapeutics' Accumulated Depreciation history runs 12 years deep, the most recent figure standing at $74000.0 for Q4 2024.
- On a quarterly basis, Accumulated Depreciation changed 0.0% year-over-year to $74000.0 in Q4 2024; TTM through Dec 2024 was $74000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at $74000.0, changed 0.0% from the prior year.
- Accumulated Depreciation steadied at $74000.0 in Q4 2024 per GALT's latest filing, from $74000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $74000.0 in Q4 2020 and bottomed at $74000.0 in Q4 2020.
- The 5-year median for Accumulated Depreciation is $74000.0 (2020), against an average of $74000.0.
- Biggest YoY gain for Accumulated Depreciation was 0.0% in 2021; the steepest drop was 0.0% in 2021.
- Year by year, Accumulated Depreciation stood at $74000.0 in 2020, then changed by 0.0% to $74000.0 in 2021, then changed by 0.0% to $74000.0 in 2022, then changed by 0.0% to $74000.0 in 2023, then changed by 0.0% to $74000.0 in 2024.
- Per Business Quant, the three latest GALT Accumulated Depreciation figures stand at $74000.0 (Q4 2024), $74000.0 (Q4 2023), and $74000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Dec 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Dec 31, 2017 | 74,000.00 |
| Dec 31, 2016 | 74,000.00 |
| Dec 31, 2015 | 74,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2013 | 71,000.00 |
| Dec 31, 2012 | 66,000.00 |
| Dec 31, 2011 | 315,000.00 |